15232767

Source:http://linkedlifedata.com/resource/pubmed/id/15232767

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008976, umls-concept:C0021294, umls-concept:C0034656, umls-concept:C0087111, umls-concept:C0105750, umls-concept:C0111318, umls-concept:C0699934, umls-concept:C0728731, umls-concept:C0771648, umls-concept:C1555580, umls-concept:C1704437, umls-concept:C1707455
pubmed:issue	5
pubmed:dateCreated	2004-7-2
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/15232767-15085492
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8405212
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Biological Agents, http://linkedlifedata.com/resource/pubmed/chemical/Phospholipids, http://linkedlifedata.com/resource/pubmed/chemical/Pulmonary Surfactants, http://linkedlifedata.com/resource/pubmed/chemical/beractant, http://linkedlifedata.com/resource/pubmed/chemical/poractant alfa
pubmed:status	MEDLINE
pubmed:month	Jul
pubmed:issn	0735-1631
pubmed:author	pubmed-author:BancalariEduardoE
pubmed:issnType	Print
pubmed:volume	21
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	307-9
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:15232767-Biological Agents, pubmed-meshheading:15232767-Humans, pubmed-meshheading:15232767-Infant, Newborn, pubmed-meshheading:15232767-Infant, Premature, pubmed-meshheading:15232767-Multicenter Studies as Topic, pubmed-meshheading:15232767-Phospholipids, pubmed-meshheading:15232767-Pulmonary Surfactants, pubmed-meshheading:15232767-Randomized Controlled Trials as Topic, pubmed-meshheading:15232767-Research Design, pubmed-meshheading:15232767-Respiratory Distress Syndrome, Newborn
pubmed:year	2004
pubmed:articleTitle	On "A randomized, multicenter masked comparison trial of poractant alfa (Curosurf) versus beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infants" (Am J Perinatol 2004;21:109-120).
pubmed:publicationType	Letter, Comment